HIV & STIs

Bixby program joins global effort to develop HIV/AIDS vaccine

UCSF Bixby Center
The UCSF Bixby Center's partnership with the University of Zimbabwe (UZ) recently joined a global research effort to develop a safe and effective vaccine to prevent HIV.

Bixby program celebrates 20 years of research in Zimbabwe

UCSF Bixby Center
This year marks the 20th anniversary of the Bixby Center's partnership with the University of Zimbabwe (UZ) in HIV/AIDS research.

Reducing HIV risk for female migrants in sub-Saharan Africa

UCSF Bixby Center
Previous research on migration and HIV in sub-Saharan Africa has primarily focused on male migrants' risk of HIV, despite the fact that equal or greater numbers of women are migrating in the region.

Integrating family planning and HIV services increases contraceptive knowledge and use

UCSF Bixby Center
A large cluster randomized trial conducted by the UCSF Bixby Center examined if integrating family planning with HIV/AIDS services can help bridge this gap and increase the use of contraception among HIV-positive women and men.

New grant will further HIV/AIDS research in Zimbabwe

UCSF Bixby Center
A UCSF Bixby Center program in Zimbabwe recently received a seven-year grant for $70 million to further its groundbreaking HIV/AIDS treatment and prevention research efforts.

Learn about the UCSF Bixby Center's international work

UCSF Bixby Center
Our 2012 Symposium is focused on the many international projects coordinated by the UCSF Bixby Center.

HPV vaccine may be linked to declining genital warts

UCSF Bixby Center
A few strains of human papillomavirus (HPV) are the major cause of cervical cancer (16 and 18) and the cause of most genital warts (6 and 11).